Everest Organics Q2 Results
- BSE: 524790
- NSE: -
- ISIN: INE334C01029
- Sector: Biotechnology & Drugs
BSE
142.8
7.20 (5.31%)
7.20 (5.31%)Volume18.26 K
Updated: Mon 25 Nov, 2024 | 15:54:09
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Everest Organics Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 23 | Jun 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 92.12 | 42.67 | -% |
| Selling/ General/ Admin Expenses Total | 9.20 | 4.54 | -% |
| Depreciation/ Amortization | 2.61 | 1.29 | -% |
| Other Operating Expenses Total | 20.98 | 10.29 | -% |
| Total Operating Expense | 89.50 | 41.44 | -% |
| Operating Income | 2.61 | 1.23 | -% |
| Net Income Before Taxes | 0.30 | 0.16 | -% |
| Net Income | 0.06 | 0.27 | -% |
| Diluted Normalized EPS | 0.08 | 0.35 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST